Overview
Updated 14 Jul 2026
Peter A. Campochiaro, MD, is George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at Wilmer Eye Institute, Johns Hopkins University School of Medicine. The public record shows 540 publications with 42,532 citations (h-index 113), centered on Retinal Diseases and Treatments, Retinal Development and Disorders, Retinal and Macular Surgery. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 9 companies, 13 NIH-funded awards (1990–2026).
- Most recent indexed publication: 2026 · bioRxiv
- Top research focus: Retinal Diseases and Treatments
- 21 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 338.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:
- Oral N-acetylcysteine for Retinitis Pigmentosa
Sponsor: Johns Hopkins University
InvestigatorPhase 3Active, not recruitingNCT05537220 - Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Sponsor: Johns Hopkins University
InvestigatorTerminatedNCT05038371 - A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa
Sponsor: Johns Hopkins University
InvestigatorTerminatedNCT04558983
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- Genentech, Inc.Program year20252 payments
NIH funding
Updated 14 Jul 2026
13 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
Johns Hopkins University
FY2026$344,858UG1EY033286 - Topical delivery of HIF-1 inhibitors for retinal and choroidal vascular diseases
Johns Hopkins University
FY2025$371,191R01EY036027 - NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
Johns Hopkins University
FY2025$302,263UG1EY033286
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
- 01
- 02Ranibizumab for Macular Edema following Central Retinal Vein Occlusion1,152 citations2010
- 03
- 04
- 05Seven new loci associated with age-related macular degeneration804 citations2013
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1800 Orleans Street, Maumenee Lobby, Baltimore, MD 21287
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Director
Retina Research Laboratory (Campochiaro Laboratory), Wilmer Eye Institute, Johns Hopkins
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Editorial Board Member
Progress in Retinal and Eye Research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencedirect.com ↗ - Member
Macula Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →maculasociety.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →arvo.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Secondary affiliationsappointments beyond the home institution
- Faculty
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuroscience.jhu.edu ↗ - Scientific Advisor
Applied Genetic Technologies Corporation (AGTC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗ - Scientific Advisor
Retina, Allegro Ophthalmics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- Eye on the Cure Podcast
Episode 67, Dr. Peter Campochiaro (Foundation Fighting Blindness, June 7 2024), discussing N-acetylcysteine (NAC) for retinitis pigmentosa
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fightingblindness.org ↗ - People Behind the Science Podcast
Episode 408, Dr. Peter Campochiaro: Bringing to Light the Mechanisms of Retinal Diseases and Developing New Treatments
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →peoplebehindthescience.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/peter-campochiaro-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/peter-campochiaro-31ba2126
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Peter-Campochiaro
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/wilmer-eye-institute-johns-hopkins-medicine_congratulations-to-dr-peter-campochiaro-activity-6664162263596834817-Ue0-
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
peoplebehindthescience.com/dr-peter-campochiaro
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →peoplebehindthescience.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harry Quigley, MD
Johns Hopkins University
- 623
- publications
- 106
- h-index
- 4
- trials
Constantine Lyketsos, MD
Johns Hopkins University
- 763
- publications
- 105
- h-index
- 5
- trials
Robert Wise, MD
Johns Hopkins University
- 1,364
- publications
- 124
- h-index
- 11
- trials
Michael Carducci, MD
Johns Hopkins University
- 1,096
- publications
- 104
- h-index
- 20
- trials